VOYAGER PAD
PAVK-Kranke nach Revaskularisation profitieren von Rivaroxaban als Add-on
Editor's Choice – External Applicability of the COMPASS and VOYAGER-PAD Trials on Patients with Symptomatic Lower Extremity Artery Disease in France: The COPART Registry - ScienceDirect
Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial | Journal of the American College of Cardiology
Voyager-Pad-Studie – Rosenfluh.ch
VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel | tctmd.com
VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban | tctmd.com
Revascularisation for Symptomatic Peripheral Artery Disease: External Applicability of the VOYAGER PAD Trial - ScienceDirect
Rivaroxaban in Peripheral Artery Disease after Revascularization | NEJM
VOYAGER PAD: Rivaroxaban plus aspirin should be considered after lower-extremity bypass regardless of conduit type - Vascular Specialist
Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial | Journal of the American College of Cardiology
New Concepts in Peripheral Artery Disease: Emerging Role of Antithrombotics. - ppt download
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial | Circulation
Neue Evidenz für Patienten mit pAVK – von der akuten bis zur chronischen Phase
VOYAGER PAD-studien: - Vil endre behandlingspraksis for en oversett pasientgruppe
VOYAGER: Clinical Trial - Post Revascularization & Chronic PAD | XARELTO® (rivaroxaban) HCP
Vorhofflimmern | NOAKs bei arteriellen Rekonstruktionen in der Gefäßmedizin | springermedizin.de
Rivaroxaban/ASS-Kombi bei PAVK wirksamer als ASS alleine
Revascularisation for Symptomatic Peripheral Artery Disease: External Applicability of the VOYAGER PAD Trial - ScienceDirect
Visual Abstract | VOYAGER PAD - American College of Cardiology
Revascularisation for Symptomatic Peripheral Artery Disease: External Applicability of the VOYAGER PAD Trial - ScienceDirect
